Hepatitis B outbreak among chimpanzees at the London Zoo

Lancet. 1978 Sep 23;2(8091):652-4. doi: 10.1016/s0140-6736(78)92761-7.

Abstract

Persistent carriage of hepatitis B virus in extremely high titre was identified in 5 out of 9 chimpanzees kept at the London Zoo. Antibody to this virus was present in the other 4 chimpanzees. Serological survey of the other primates in the Regent's Park collection did not reveal the presence of the surface antigen in 2 gorillas, 11 orang-utans, and 2 gibbons, although surface antibody was present in the serum of 1 gorilla and 2 orang-utans. 3 of the carrier chimpanzees were born at the Zoo and were the offspring of either a carrier mother or a carrier father, and perinatal transmission may have occurred. A strict safety code of practice was introduced and hepatitis B immunoglobulin was given at intervals to designated staff members. Sero-conversion did not occur in any of the 38 staff members under surveillance for more than 2 years. Treatment of the carrier state in the chimpanzees was attempted with human leucocyte interferon, with and without ribavirin ('Virazole'), and with adenine arabinoside, but the effects were mostly temporary.

MeSH terms

  • Animals
  • Animals, Zoo*
  • Carrier State / immunology
  • Carrier State / therapy
  • Carrier State / veterinary*
  • Disease Outbreaks / veterinary*
  • Hepatitis B / immunology
  • Hepatitis B / therapy
  • Hepatitis B / veterinary*
  • Hepatitis B Antibodies / isolation & purification
  • Hepatitis B Surface Antigens / isolation & purification
  • Hepatitis, Animal* / immunology
  • Hepatitis, Animal* / therapy
  • Humans
  • Interferons / therapeutic use
  • London
  • Pan troglodytes*
  • Ribavirin / therapeutic use
  • Vidarabine / therapeutic use

Substances

  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens
  • Ribavirin
  • Interferons
  • Vidarabine